Electromed (NYSE:ELMD) Rating Increased to Strong-Buy at StockNews.com

Electromed (NYSE:ELMD - Get Free Report) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Wednesday.

Separately, TheStreet raised Electromed from a "c+" rating to a "b-" rating in a report on Wednesday, February 21st.

Electromed Price Performance

ELMD stock traded down $0.09 during mid-day trading on Wednesday, reaching $14.88. 20,807 shares of the company traded hands, compared to its average volume of 28,847. The company has a market capitalization of $128.12 million, a P/E ratio of 33.07 and a beta of 0.43. Electromed has a 52-week low of $8.80 and a 52-week high of $17.85. The company has a fifty day moving average price of $14.74 and a 200-day moving average price of $11.95.

Electromed (NYSE:ELMD - Get Free Report) last issued its quarterly earnings data on Tuesday, February 13th. The company reported $0.19 EPS for the quarter. Electromed had a return on equity of 10.32% and a net margin of 7.62%. The company had revenue of $13.69 million during the quarter.

Institutional Trading of Electromed

Several hedge funds and other institutional investors have recently bought and sold shares of ELMD. Cetera Advisor Networks LLC bought a new position in Electromed during the second quarter valued at approximately $129,000. State Street Corp grew its position in Electromed by 23.3% during the first quarter. State Street Corp now owns 14,529 shares of the company's stock valued at $181,000 after acquiring an additional 2,742 shares during the last quarter. Gabelli Funds LLC grew its holdings in shares of Electromed by 17.3% in the fourth quarter. Gabelli Funds LLC now owns 20,367 shares of the company's stock worth $222,000 after purchasing an additional 3,000 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Electromed by 7.6% in the second quarter. BlackRock Inc. now owns 20,521 shares of the company's stock worth $220,000 after purchasing an additional 1,452 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Electromed by 4.7% in the second quarter. Northern Trust Corp now owns 29,078 shares of the company's stock worth $311,000 after purchasing an additional 1,306 shares during the last quarter. Hedge funds and other institutional investors own 40.82% of the company's stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.